Udg Healthcare PLC (LON:UDG) Receives GBX 747.50 Average PT from Brokerages
Udg Healthcare PLC (LON:UDG) has been assigned a consensus recommendation of “Hold” from the seven research firms that are currently covering the company, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is GBX 747.50 ($9.77).
A number of brokerages have recently issued reports on UDG. Numis Securities raised Udg Healthcare to a “hold” rating in a report on Thursday, May 16th. Liberum Capital reaffirmed a “buy” rating on shares of Udg Healthcare in a research note on Wednesday, August 7th. Berenberg Bank raised their price objective on shares of Udg Healthcare from GBX 700 ($9.15) to GBX 850 ($11.11) and gave the stock a “hold” rating in a report on Tuesday, August 20th. Peel Hunt reiterated a “buy” rating on shares of Udg Healthcare in a research note on Monday, September 2nd. Finally, Royal Bank of Canada downgraded Udg Healthcare to a “sector performer” rating and reduced their target price for the stock from GBX 830 ($10.85) to GBX 800 ($10.45) in a report on Monday, August 12th.
Shares of LON:UDG traded up GBX 1 ($0.01) on Friday, hitting GBX 762 ($9.96). The company had a trading volume of 636,300 shares, compared to its average volume of 981,360. The firm has a market capitalization of $1.90 billion and a price-to-earnings ratio of 73.98. Udg Healthcare has a 1 year low of GBX 545 ($7.12) and a 1 year high of GBX 833 ($10.88). The company has a quick ratio of 1.85, a current ratio of 1.94 and a debt-to-equity ratio of 26.96. The firm’s 50-day simple moving average is GBX 790.24 and its two-hundred day simple moving average is GBX 695.89.
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.
Featured Article: Accumulation/Distribution
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.